No verbatim quote is on file for this clause. The finding should be checked against the full produced record.
Why this verdict
Three of five models read this as missing; Claude Opus 5 and Kimi K3 called it bad because Section 3.8 on page 4 makes IPM an independent contractor and not an agent of the county. We re-read pages 2 to 4 and the relationship clause in Section 16 on page 9. Nothing imposes a duty of loyalty or care on IPM, requires disclosure of conflicts, or provides for disgorgement, and the independent contractor language describes the legal relationship rather than authorizing self dealing. Under the majority rule the item is not addressed rather than contradicted, and the minority reading is recorded here.
Compare with the model contract · § Section 2.4
The PBM owes duties of loyalty and care solely to the plan and its members, must disclose all direct and indirect compensation and every economic conflict, and must disgorge anything retained in breach without the plan proving damages.
Without a loyalty duty the PBM is free to put its own affiliates and revenue ahead of the plan when it exercises discretion over formularies, networks and pricing.
Where the council disagreed 5 published readings
Only readings under the score’s rubric version are shown here. Model confidence and agreement do not establish legal correctness.
Claude Opus 5Contradicts the model
The agreement owes IPM no duty of loyalty to the county or its members. Section 3.8 makes IPM an independent contractor and expressly not an agent of the county, and it disclaims any final discretionary authority, while nothing elsewhere requires IPM to act in the plan's interest or to give up money it keeps improperly. The model contract published by Mark Cuban and collaborators puts a duty of loyalty and care on the pharmacy benefit manager and requires disgorgement of retained amounts. This text does the opposite of that.
Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client.
Page 4 · Rubric v2
Gemini 3.1 ProNot addressed
The contract does not establish any fiduciary duty or duty of loyalty. In Section 3.8 on page 4, the contract explicitly states that IPM operates as an independent contractor and has no final discretionary authority or responsibility for the administration of the plans.
No page citation · Rubric v2
GPT 5.6 SolNot addressed
The responsibilities provisions on pages 2 to 4 and the relationship clause on page 9 do not impose duties of loyalty or care on IPM. The agreement contains no fiduciary duty, conflict disclosure duty, or disgorgement remedy.
No page citation · Rubric v2
Grok 4.6Not addressed
The definitions on pages 1 to 2, IPM duties on pages 2 to 3, Client duties including section 3.8 on page 4, the independent contractor clause in section 16 on page 9, and the ERISA sentence in section 19.1 on page 9 do not impose any duty of loyalty or care on IPM. Section 3.8 says IPM is an independent contractor with no final discretionary authority over the Plans, which is not a loyalty duty to the County or members. There is no conflict disclosure and no disgorgement remedy of the kind in the model contract published by Mark Cuban and collaborators.
No page citation · Rubric v2
Kimi K3Contradicts the model
The model contract published by Mark Cuban and collaborators makes the PBM owe duties of loyalty and care to the plan and its members. This agreement does the opposite: it frames IPM as an arm's length independent contractor, states that IPM has no discretionary authority or responsibility for plan administration, and nowhere imposes any duty of loyalty, care, or disclosure of conflicts. IPM also disclaims liability for its drug utilization review and network pharmacy decisions. There is no fiduciary obligation of any kind in the text.
Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client
Page 4 · Rubric v2
Finding provenance
Finding ID
c62d11b9-f942-40ab-8772-ea0853e1a0f2
Reviewed
Sep 30, 2026
Reviewer
owner
Recorded confidence
0.6
Model votes
Kimi K3: bad; Grok 4.6: missing; GPT 5.6 Sol: missing; Claude Opus 5: bad; Gemini 3.1 Pro: missing
Published reports 3 write-ups
Published Sep 30, 2026
Good news, bad news: the short version
Good news
The whole document is public. All 17 pages, including the Exhibit A fee schedule (page 11), are posted and readable, so nothing had to be excluded from the score.
The county keeps control of its plan. Section 3.8 (page 4) says the county has the sole authority to control and administer its plans, and Sections 3.1 and 3.2 (page 3) put the benefit design in the county's hands.
Members cannot be balance billed. Section 5.7 (page 5) bars IPM and network pharmacies from collecting anything from covered persons beyond copayments and deductibles, and the clause survives termination.
No termination fee. Section 4 (page 4) lets either party end the agreement on 90 days written notice with no penalty stated, and the fiscal funding clause in Section 27 (page 12) ties every renewal to the commissioners court approving a budget.
Most ancillary services are free. Exhibit A (page 11) prices ID cards, claim forms, prior authorizations, standard reporting and four other services at $0.00 each.
Amendments are supposed to be signed. Section 18 (page 9) requires mutual written consent for changes, as a default rule.
Bad news
No rebates come back. Nothing in the agreement gives the county any manufacturer revenue, and the only mentions of rebates (pages 4 and 10) concern member disclosure and taxes.
Spread is allowed. The county pays average wholesale price formulas under Exhibit A (page 11) while pharmacies are paid under IPM's separate agreements (Section 5.8, page 5), and nothing requires the two amounts to match.
IPM can raise prices alone. Section 5.3 (page 4) lets IPM change the fees or other pricing after the initial term by delivering documentation before the budget cycle, which hollows out the signed amendment rule.
The vendor picks the pharmacies. Section 2.3 (page 2) makes network additions and deletions IPM's sole discretion with no any willing pharmacy right, and Section 5.8 (page 5) makes the county pay whenever a pharmacy later claims an underpayment.
The vendor owns the data and may reuse it. Section 7.1 (page 6) lets IPM use member information in any manner it deems appropriate, including product research, and Section 6.5 makes the databases and report formats IPM's property.
The county cannot audit the money. The only audit right is in the business associate agreement (page 16) and covers privacy compliance; reports are deemed accurate if not disputed within 45 days (page 3) and disputed invoices must be paid in full (page 5).
Pricing is confidential. Section 6.1 (page 5) treats pricing information and the agreement with all exhibits as confidential, with no Texas Public Information Act carve out.
Remedies are capped. Section 9.6 (page 7) limits IPM's total liability to the administrative fee paid over the previous six months.
Exclusivity plus auto renewal. Section 10 (page 8) makes IPM the county's exclusive PBM, and the term renews yearly unless notice lands before the term ends (page 4).
The number
The reconciled score is 8.5 out of 100, a Red flag, on 100 points of scored weight with nothing unclear, and the gag clause flag is set. Four items earned half credit (MAC governance, formulary control, audit rights and termination) and everything else scored zero, either because the text contradicts the model contract by Mark Cuban and collaborators or because it says nothing. What would move the number most is a full pass through of manufacturer revenue, worth 11 points, followed by a plain statement that the county pays exactly what the pharmacy is paid plus a disclosed fee, worth 9. Removing pricing from the confidentiality clause would not change the score but would clear the red flag.
Request a signed agreement, later amendments, incorporated proposals or any missing exhibits as needed. A full-contract label does not confirm that the posted copy is signed.
The reference is the open source PBM contract published by Mark Cuban and collaborators, version 3.5. BetterBuy Rx did not write it and is not affiliated with or endorsed by its authors. Read the original model contract.